SWISS-MODEL web services will be unavailable between 08:00 CET and 10:00 CET, Thursday, 14th November.
Jobs started before this time will not be affected.

Q92831 (KAT2B_HUMAN) Homo sapiens (Human)

Histone acetyltransferase KAT2B UniProtKBInterProSTRINGInteractive Modelling

832 aa; Sequence (Fasta)

Available Structures

25 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
The Structural Basis for Site-Specific Lysine-Acetylated Histone Recognition by the Bromodomains of… Heteromer
P61830;
719-832
100
NMR Structure of P/CAF Bromodomain in Complex with HIV-1 Tat Peptide Heteromer
P04610;
719-832
100
The Structural Basis for Site-Specific Lysine-Acetylated Histone Recognition by the Bromodomains of… Heteromer
P61830;
719-832
100
Crystal structure of PCAFhomo-2-mer493-652
100.0COA;
Crystal structure of human PCAF bromodomain in complex with compound-E (CPD-E)homo-2-mer723-831
100EDO;78Y;DMS;
Crystal structure of human PCAF bromodomain in complex with compound SL1122 (compound 13)homo-2-mer723-831
1005WS;EDO;
Crystal structure of human PCAF bromodomain in complex with compound BDOMB00091a (compound 14)homo-2-mer724-830
1005X0;EDO;
CRYSTAL STRUCTURE OF THE PCAF/COENZYME-A COMPLEXmonomer492-653
99.38COA;
complex structure of PCAF bromodomain with small chemical ligand NP1monomer719-832
100NP1;
Complex structure of PCAF bromodomain with small chemical ligand NP2monomer719-832
100NP2;
Structure and Ligand of a Histone Acetyltransferase Bromodomainmonomer719-832
100
Structure-based evaluation of selective and non-selective small molecules that block HIV-1 TAT and …monomer719-832
100MIB;
Crystal structure of human PCAF bromodomain in complex with fragment ZB1916 (fragment 10)monomer723-831
100EDO;5WZ;
Crystal structure of human PCAF bromodomain in complex with fragment ZB2216 (fragment 11)monomer723-831
100EDO;5WU;
Crystal structure of human PCAF bromodomain in complex with fragment MB360 (fragment 4)monomer723-831
100EDO;5WX;
Crystal structure of human PCAF bromodomain in complex with compound-D (CPD-D), N-methyl-2-(tetrahy…monomer724-831
100EDO;2LX;
Crystal structure of human PCAF bromodomain in complex with compound SL1126 (compound 12)monomer724-831
1005WT;EDO;
Crystal structure of human PCAF bromodomain in complex with fragment MB093 (fragment 7)monomer724-831
100EDO;DMS;
Crystal structure of human PCAF bromodomain in complex with fragment MB364 (fragment 5)monomer724-831
100EDO;5WY;
Crystal structure of human PCAF bromodomain in complex with fragment BR004 (fragment 1)monomer724-831
10012Q;
Crystal structure of human PCAF bromodomain in complex with acetyllysinemonomer724-831
100ALY;
Crystal structure of human PCAF bromodomain in complex with fragment BR013 (fragment 3)monomer725-831
1005WV;EDO;
Crystal Structure of the Bromodomain of Human PCAFmonomer725-831
100CL;
1.68A STRUCTURE PCAF BROMODOMAIN WITH 4-chloro-2-methyl-5-(methylamino)pyridazin-3(2H)-onemonomer726-831
10082I;SO4;EPE;
Crystal structure of the human PCAF bromodomain in complex with compound 12monomer726-831
100B4L;

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7by1.1.Amonomer0.7976-372
ZN;70.74
3d7c.1.Amonomer0.76724-832
74.31
6cw2.2.Amonomer0.69477-707
49.78